Angela Burgess

Angela Burgess

Auto-generated profile, based on publicly available information

Angela Burgess

Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
ABAngela P.H. Burgess
Angela P.H. Burgess
DDDeepa Dongarwar
Deepa Dongarwar
ZSZachary Spigel
Zachary Spigel
HSHamisu M. Salihu
Hamisu M. Salihu
AMAmirhossein Moaddab
Amirhossein Moaddab
KFKarin Fox
Karin Fox

1 January 2019 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
GVGregory Valentine
Gregory Valentine
ABAngela Burgess
Angela Burgess
JHJoseph Hagan
Joseph Hagan
MGManisha Gandhi
Manisha Gandhi
NHNancy Hurst
Nancy Hurst
AHAmy Hair
Amy Hair

1 November 2010 in Biology of Reproduction
Verified
Journal Article
Open access
Jennifer HillJennifer Hill
Jennifer Hill
ABAngela Burgess
Angela Burgess
JBJens C. Bruning
Jens C. Bruning
BLBradford B. Lowell
Bradford B. Lowell
JEJoel K. Elmquist
Joel K. Elmquist
Nader G. AbrahamNader G. Abraham
Nader G. Abraham
Polycystic ovarian syndrome often presents alongside the metabolic syndrome: obesity, impaired glucose tolerance and type 2 diabetes, hyperlipidemia, chronic low-grade inflammation, and early-stage atherosclerosis. We have recently demonstrated that mice with impaired insulin and leptin signaling in POMC neurons exhibit a PCOS-like phenotype including systemic insulin resistance, elevated serum testosterone levels and ovarian abnormalities resulting in reduced fertility. In a separate study, we have recently shown that an HDL analog reduces cardiovascular risk factors independent of body weight, improves insulin sensitivity, reduces testosterone levels and increases estradiol levels in obese leptin-deficient female mice. We hypothesize that inflammation, insulin resistance, and elevated triglyceride levels contribute to the impairment of reproductive functioning in ob/ob and POMC-cre,LepRfloxIRflox mice. To test our hypothesis, we have administered L4-F, gemfibrozil, flutamide, metformin, and pioglitazone to separate cohorts to examine the ability of these drugs to improve fertility. Our results demonstrate that increased insulin sensitivity improves ovarian functioning in these mice and provide some insight into mechanisms involved. Thus, these mouse models offer a novel approach for examining the etiology and treatment of obesity-associated infertility. Research supported by NICHD HD056491 to JWH. (poster)